Fig. 2From: Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusionTime to achievement of 20/40 or better vision by baseline total macular volume. Excludes 22 (10.9%) patients with 20/40 or better vision at baseline; total macular volume was measured by the digital angiography reading center using spectral-domain optical coherence tomographyBack to article page